ARTICLE | Preclinical News
FLT3 inhibitor reduces peripheral neuropathic pain
March 14, 2018 7:51 PM UTC
A study published in Nature Communications suggests that inhibiting FMS-like tyrosine kinase 3 (FLT3; CD135) with a small molecule inhibitor could help treat peripheral nerve pain.
Current therapies to treat peripheral nerve pain, including off-label antidepressants and anti-epileptics, are often ineffective and have multiple side effects...
BCIQ Company Profiles
Institut National de la Sante et de la Recherche Medicale (INSERM)
BCIQ Target Profiles